Showing results 6 to 19 of 19
< previous
| Issue Date | Title | Author(s) |
| 2020-11-27 | High-Plex and High-Throughput Digital Spatial Profiling of Non-Small-Cell Lung Cancer (NSCLC). | Monkman, J; Taheri, T; Ebrahimi Warkiani, M; O'Leary, C; Ladwa, R; Richard, D; O'Byrne, K; Kulasinghe, A |
| 2022 | IFI27 transcription is an early predictor for COVID-19 outcomes, a multi-cohort observational study. | Shojaei, M; Shamshirian, A; Monkman, J; Grice, L; Tran, M; Tan, CW; Teo, SM; Rodrigues Rossi, G; McCulloch, TR; Nalos, M; Raei, M; Razavi, A; Ghasemian, R; Gheibi, M; Roozbeh, F; Sly, PD; Spann, KM; Chew, KY; Zhu, Y; Xia, Y; Wells, TJ; Senegaglia, AC; Kuniyoshi, CL; Franck, CL; Dos Santos, AFR; de Noronha, L; Motamen, S; Valadan, R; Amjadi, O; Gogna, R; Madan, E; Alizadeh-Navaei, R; Lamperti, L; Zuñiga, F; Nova-Lamperti, E; Labarca, G; Knippenberg, B; Herwanto, V; Wang, Y; Phu, A; Chew, T; Kwan, T; Kim, K; Teoh, S; Pelaia, TM; Kuan, WS; Jee, Y; Iredell, J; O'Byrne, K; Fraser, JF; Davis, MJ; Belz, GT; Warkiani, ME; Gallo, CS; Souza-Fonseca-Guimaraes, F; Nguyen, Q; Mclean, A; Kulasinghe, A; Short, KR; Tang, B |
| 2023-02 | Immunotherapeutic targets in non-small cell lung cancer. | Sadeghirad, H; Bahrami, T; Layeghi, SM; Yousefi, H; Rezaei, M; Hosseini-Fard, SR; Radfar, P; Warkiani, ME; O'Byrne, K; Kulasinghe, A |
| 2019-03-18 | Phenotypic Characterization of Circulating Lung Cancer Cells for Clinically Actionable Targets. | Kulasinghe, A; Kapeleris, J; Cooper, C; Warkiani, ME; O'Byrne, K; Punyadeera, C |
| 2018-08-14 | The prognostic role of circulating tumor cells (CTCs) in lung cancer | Kapeleris, J; Kulasinghe, A; Warkiani, ME; Vela, I; Kenny, L; O'Byrne, K; Punyadeera, C |
| 2022-07 | Prognostic value of integrating circulating tumour cells and cell-free DNA in non-small cell lung cancer. | Kapeleris, J; Müller Bark, J; Ranjit, S; Irwin, D; Hartel, G; Warkiani, ME; Leo, P; O'Leary, C; Ladwa, R; O'Byrne, K; Hughes, BGM; Punyadeera, C |
| 2016-09-13 | Short term ex-vivo expansion of circulating head and neck tumour cells. | Kulasinghe, A; Perry, C; Warkiani, ME; Blick, T; Davies, A; O'Byrne, K; Thompson, EW; Nelson, CC; Vela, I; Punyadeera, C |
| 2020-01 | The evolving landscape of predictive biomarkers in immuno-oncology with a focus on spatial technologies. | Sadeghi Rad, H; Bazaz, SR; Monkman, J; Ebrahimi Warkiani, M; Rezaei, N; O'Byrne, K; Kulasinghe, A |
| 2021-07-19 | The Pandora’s Box of novel technologies that may revolutionize lung cancer | Rad, HS; Rad, HS; Shiravand, Y; Radfar, P; Arpon, D; Warkiani, ME; O'Byrne, K; Kulasinghe, A |
| 2021 | The Role of Circulating Biomarkers in Lung Cancer. | Herath, S; Sadeghi Rad, H; Radfar, P; Ladwa, R; Warkiani, M; O'Byrne, K; Kulasinghe, A |
| 2020-06-15 | The Use of Three-Dimensional DNA Fluorescent In Situ Hybridization (3D DNA FISH) for the Detection of Anaplastic Lymphoma Kinase (ALK) in Non-Small Cell Lung Cancer (NSCLC) Circulating Tumor Cells. | Kulasinghe, A; Lim, Y; Kapeleris, J; Warkiani, M; O'Byrne, K; Punyadeera, C |
| 2021-01-01 | Understanding the tumor microenvironment for effective immunotherapy. | Sadeghi Rad, H; Monkman, J; Warkiani, ME; Ladwa, R; O'Byrne, K; Rezaei, N; Kulasinghe, A |
| 2022 | Understanding the tumor microenvironment in head and neck squamous cell carcinoma. | Rad, HS; Shiravand, Y; Radfar, P; Ladwa, R; Perry, C; Han, X; Warkiani, ME; Adams, MN; Hughes, BG; O'Byrne, K; Kulasinghe, A |
| 2024 | Whole transcriptome profiling of placental pathobiology in SARS-CoV-2 pregnancies identifies placental dysfunction signatures. | Stylianou, N; Sebina, I; Matigian, N; Monkman, J; Doehler, H; Röhl, J; Allenby, M; Nam, A; Pan, L; Rockstroh, A; Sadeghirad, H; Chung, K; Sobanski, T; O'Byrne, K; Almeida, ACSF; Rebutini, PZ; Machado-Souza, C; Stonoga, ETS; Warkiani, ME; Salomon, C; Short, K; McClements, L; de Noronha, L; Huang, R; Belz, GT; Souza-Fonseca-Guimaraes, F; Clifton, V; Kulasinghe, A |
